Integrating Immunotherapy into Multimodal Treatment of Head and Neck Cancer

Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) have a poor prognosis, with a significant risk of progression or death despite multimodal treatment with surgery, chemotherapy, and radiotherapy. Immune checkpoint inhibitors targeting the programmed death receptor-1 (PD1)...

Full description

Bibliographic Details
Main Authors: Yuan James Rao, Joseph F. Goodman, Faysal Haroun, Julie E. Bauman
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/3/672